StreetInsider
Log in to your account:
Log in
Signup
Home
EPS Insider
Event Calendar
Conferences
Classic Site
Upgrade to SI Premium - Free Trial
Gilead Sciences (GILD) PT Raised to $65 at BMO Capital
January 12, 2021 6:27 AM
BMO Capital analyst Matthew Luchini raised the price target on Gilead Sciences (NASDAQ: GILD) to $65.00 (from $62.00) while maintaining ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
Categories
Analyst Comments
Analyst PT Change